BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32055444)

  • 1. Molecular analysis of the human placental cysteine dioxygenase type 1 gene.
    Dawson PA; Weerasekera SJ; Atcheson RJ; Twomey SA; Simmons DG
    Mol Genet Metab Rep; 2020 Mar; 22():100568. PubMed ID: 32055444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of sequence and splice variants of the human SLC13A4 sulfate transporter.
    Zhang Z; Aung ZT; Simmons DG; Dawson PA
    Mol Genet Metab; 2017 May; 121(1):35-42. PubMed ID: 28385533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placental and fetal cysteine dioxygenase gene expression in mouse gestation.
    Rakoczy J; Lee S; Weerasekera SJ; Simmons DG; Dawson PA
    Placenta; 2015 Aug; 36(8):956-9. PubMed ID: 26119969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cysteine dioxygenase 1 is a tumor suppressor gene silenced by promoter methylation in multiple human cancers.
    Brait M; Ling S; Nagpal JK; Chang X; Park HL; Lee J; Okamura J; Yamashita K; Sidransky D; Kim MS
    PLoS One; 2012; 7(9):e44951. PubMed ID: 23028699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cysteine dioxygenase type 1 promotes adipogenesis via interaction with peroxisome proliferator-activated receptor gamma.
    Deng P; Chen Y; Ji N; Lin Y; Yuan Q; Ye L; Chen Q
    Biochem Biophys Res Commun; 2015 Feb; 458(1):123-7. PubMed ID: 25637537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of cysteine dioxygenase 1 in complex karyotype liposarcomas.
    Shaker M; Pascarelli KM; Plantinga MJ; Love MA; Lazar AJ; Ingram DR; von Mehren M; Lev D; Kipling D; Broccoli D
    Biomark Cancer; 2014; 6():1-10. PubMed ID: 24741338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipose tissue cysteine dioxygenase type 1 is associated with an anti-inflammatory profile, impacting on systemic metabolic traits.
    Latorre J; Mayneris-Perxachs J; Oliveras-Cañellas N; Ortega F; Comas F; Fernández-Real JM; Moreno-Navarrete JM
    EBioMedicine; 2022 Nov; 85():104302. PubMed ID: 36206624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Significance of Promoter DNA Hypermethylation of cysteine dioxygenase 1 (CDO1) Gene in Primary Breast Cancer.
    Minatani N; Waraya M; Yamashita K; Kikuchi M; Ushiku H; Kojo K; Ema A; Nishimiya H; Kosaka Y; Katoh H; Sengoku N; Tanino H; Sidransky D; Watanabe M
    PLoS One; 2016; 11(1):e0144862. PubMed ID: 26785325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDO1 promoter methylation is associated with gene silencing and is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients.
    Meller S; Zipfel L; Gevensleben H; Dietrich J; Ellinger J; Majores M; Stein J; Sailer V; Jung M; Kristiansen G; Dietrich D
    Epigenetics; 2016 Dec; 11(12):871-880. PubMed ID: 27689475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cysteine dioxygenase type 1 (CDO1): Its functional role in physiological and pathophysiological processes.
    Chen M; Zhu JY; Mu WJ; Guo L
    Genes Dis; 2023 May; 10(3):877-890. PubMed ID: 37396540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter methylation of cysteine dioxygenase type 1: gene silencing and tumorigenesis in hepatocellular carcinoma.
    Choi JI; Cho EH; Kim SB; Kim R; Kwon J; Park M; Shin HJ; Ryu HS; Park SH; Lee KH
    Ann Hepatobiliary Pancreat Surg; 2017 Nov; 21(4):181-187. PubMed ID: 29264579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent inactivation of cysteine dioxygenase type 1 contributes to survival of breast cancer cells and resistance to anthracyclines.
    Jeschke J; O'Hagan HM; Zhang W; Vatapalli R; Calmon MF; Danilova L; Nelkenbrecher C; Van Neste L; Bijsmans IT; Van Engeland M; Gabrielson E; Schuebel KE; Winterpacht A; Baylin SB; Herman JG; Ahuja N
    Clin Cancer Res; 2013 Jun; 19(12):3201-11. PubMed ID: 23630167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-specific promoter DNA methylation of Cysteine dioxygenase type 1 (CDO1) gene as an important prognostic biomarker of gastric cancer.
    Harada H; Hosoda K; Moriya H; Mieno H; Ema A; Ushiku H; Washio M; Nishizawa N; Ishii S; Yokota K; Tanaka Y; Kaida T; Soeno T; Kosaka Y; Watanabe M; Yamashita K
    PLoS One; 2019; 14(4):e0214872. PubMed ID: 30934021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual effect of a single nucleotide polymorphism in the first intron of the porcine secreted phosphoprotein 1 gene: allele-specific binding of C/EBP beta and activation of aberrant splicing.
    Muráni E; Ponsuksili S; Seyfert HM; Shi X; Wimmers K
    BMC Mol Biol; 2009 Oct; 10():96. PubMed ID: 19845957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of methylated CDO1 in plasma of colorectal cancer; a PCR study.
    Yamashita K; Waraya M; Kim MS; Sidransky D; Katada N; Sato T; Nakamura T; Watanabe M
    PLoS One; 2014; 9(12):e113546. PubMed ID: 25469504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of
    Chen X; Poetsch A
    Biomedicines; 2024 Apr; 12(4):. PubMed ID: 38672271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of placental FLT1 transcript variants relates to both gestational hypertensive disease and fetal growth.
    Jebbink J; Keijser R; Veenboer G; van der Post J; Ris-Stalpers C; Afink G
    Hypertension; 2011 Jul; 58(1):70-6. PubMed ID: 21518965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sézary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3.
    Booken N; Gratchev A; Utikal J; Weiss C; Yu X; Qadoumi M; Schmuth M; Sepp N; Nashan D; Rass K; Tüting T; Assaf C; Dippel E; Stadler R; Klemke CD; Goerdt S
    Leukemia; 2008 Feb; 22(2):393-9. PubMed ID: 18033314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of the human SLC13A4 sulfate transporter gene promoter.
    Jefferis J; Rakoczy J; Simmons DG; Dawson PA
    Biochem Biophys Res Commun; 2013 Mar; 433(1):79-83. PubMed ID: 23485456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylated cysteine dioxygenase-1 gene promoter in the serum is a potential biomarker for hepatitis B virus-related hepatocellular carcinoma.
    Yang Y; Fan YC; Gao S; Dou CY; Zhang JJ; Sun FK; Wang K
    Tohoku J Exp Med; 2014 Mar; 232(3):187-94. PubMed ID: 24646840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.